Copyright
©The Author(s) 2021.
World J Clin Cases. Aug 16, 2021; 9(23): 6798-6803
Published online Aug 16, 2021. doi: 10.12998/wjcc.v9.i23.6798
Published online Aug 16, 2021. doi: 10.12998/wjcc.v9.i23.6798
Figure 1 Psoriasis lesion sites before treatment.
A: The psoriasis lesion sites on the hands and wrists before transplantation of minimally manipulated umbilical cord-derived mesenchymal stem cells (MM-UC-MSCs); B: The ear before transplantation of MM-UC-MSCs.
Figure 2 Graph for Psoriasis Area and Severity Index and Dermatology Life Quality Index score change in a patient with psoriasis according to the procedure outcomes.
DLQI: Dermatology Life Quality Index; PASI: Psoriasis Area and Severity Index.
Figure 3 Visible changes at the lesion sites on the patient during and after treatment.
A and B: The erythema changes of both hands and wrist observed at day 15 (A) and day 122 (B) after the 1st transplant; C: The erythema of the ear lesion site at day 122 after the 1st transplant.
- Citation: Ahn H, Lee SY, Jung WJ, Pi J, Lee KH. Psoriasis treatment using minimally manipulated umbilical cord-derived mesenchymal stem cells: A case report. World J Clin Cases 2021; 9(23): 6798-6803
- URL: https://www.wjgnet.com/2307-8960/full/v9/i23/6798.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i23.6798